Argos Therapeutics, Inc. announced the formation of the company's first Scientific Advisory Board (SAB). Inaugural members of Argos' SAB include: Charles Drake, MD, PhD, co-director division of immunology, professor of medical oncology, immunology, and urology at the Johns Hopkins Sidney Kimmel Cancer Center; Robert Figlin, MD, FACP, Steven Spielberg Family chair in hematology oncology and professor of medicine and biomedical sciences at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute; Bernard Fox, PhD, Harder Family chair for cancer research, member and chief of the laboratory of molecular and tumor immunology at Earle A. Chiles Research Institute, Providence Portland Medical Center; Gerald Linette, MD, PhD, associate professor of medicine and neurosurgery, division of oncology at the Washington University School of Medicine in St. Louis; Thomas Schwaab, MD, PhD, chief of strategy, business development and outreach and associate professor of oncology at Roswell Park Cancer Institute and Robert Seder, MD, chief of the cellular immunology section, vaccine research center, at the National Institute of Allergy and Infectious Diseases, National Institutes of Health.